To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Multiple Sclerosis: Health Services
Thursday 10th July 2025

Asked by: Olly Glover (Liberal Democrat - Didcot and Wantage)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the NHS England Getting It Right First Time neurology programme on the (a) quality and (b) consistency of multiple sclerosis care.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Getting it Right First Time (GIRFT) National Specialty Report made recommendations designed to improve neurology services nationally and to support the National Health Service to deliver care more equitably across the country. The National Specialty Report highlighted differences in how services are delivered and offered an unprecedented opportunity to share successful initiatives between trusts to improve patient services nationally.

Building on the GIRFT National Specialty Report, the Neurology Transformation Programme has developed a model of integrated care for neurology services to support integrated care boards to deliver the right service, at the right time for all neurology patients, including those with multiple sclerosis (MS). This focuses on providing access equitably across the country, care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions.

The Neurology Transformation Programme has developed a national data dashboard for integrated care systems to monitor delivery of MS care, including for disease-modifying therapies. Additionally, NHS England has also developed guidance for systems on improving access to disease-modifying treatments for MS closer to home, which includes successful delivery models and good practice case studies.

The Neurology Transformation Programme is working with the National Clinical Director for Neurology and the Neurology Clinical Reference Group to develop a revised service specification for neurology. The updated service specification will further build on the specific recommendations in the GIRFT report and will include specific guidance for pathways for MS and other neuroinflammatory conditions.


Written Question
Employment: Multiple Sclerosis
Wednesday 9th July 2025

Asked by: Olly Glover (Liberal Democrat - Didcot and Wantage)

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what steps she has taken with Cabinet colleagues to help ensure that people with multiple sclerosis are supported to remain in employment through (a) flexible working arrangements and (b) effective symptom management closer to home.

Answered by Alison McGovern - Minister of State (Housing, Communities and Local Government)

Good work is generally good for health and wellbeing, so we want everyone to get work and get on in work, whoever they are and wherever they live. Disabled people and people with health conditions, including multiple sclerosis, are a diverse group so access to the right work and health support, in the right place, at the right time, is key. We therefore have a range of specialist initiatives to support individuals to stay in work and get back into work, including those that join up employment and health systems. Measures include support from Work Coaches and Disability Employment Advisers in Jobcentres and Access to Work grants, as well as joining up health and employment support around the individual through Employment Advisors in NHS Talking Therapies and Individual Placement and Support in Primary Care.

Building on our WorkWell, Employment Advisers in Talking Therapies and Connect to Work programmes, we will ensure people with a health condition have access to the holistic support they need. In the Government’s Pathways to Work Green Paper, we further committed to developing a support guarantee, so that disabled people and those with a health condition get the work, health and skills support they need to access and thrive in employment.

And we are delivering the biggest investment in support for disabled people and people with health conditions in at least a generation. Our support guarantee announced as part of the Green Paper is backed up by £2.2bn over four years, including £200m in 2026/27 when our benefit changes begin to take effect and, as announced in the statement on Welfare Reform (30 June) by the Secretary of State for Work and Pensions, an additional £300m over the next 3 years. This brings our total investment in employment support for disabled people and those with health conditions to £3.8 billion over this Parliament.

We will further pilot the integration of employment advisers and work coaches into the neighbourhood health service, so that working age people with long term health conditions have an integrated public service offer. A patient’s employment goals will be part of care plans, to support more joined up service provision. The Department for Work and Pensions and the Department of Health and Social Care have worked together on the 10 Year Health Plan. The 10 Year Health Plan will ensure a better health service for everyone, regardless of condition or service area. The Plan sets out the vision for what good joined-up care looks like for people with a combination of health and care needs, including for disabled people.

Backed by £240m investment, the Get Britain Working White Paper launched in November 2024, will drive forward approaches to tackling economic inactivity and work toward the long-term ambition of an 80% employment rate. In recognition of the key role employers play a key role in increasing employment opportunities and supporting disabled people and people with health conditions, the Secretaries of State for Work and Pensions and Business and Trade asked Sir Charlie Mayfield to lead an independent review, considering how best to support and enable employers to recruit and retain more people with health conditions and disabilities, promote healthy workplaces, and support more people to stay in or return to work from periods of sickness absence. Sir Charlie will deliver his final report in the autumn. Employers are crucial in enhancing employment opportunities and supporting disabled people and those with health conditions to thrive in the workforce. Our support to employers includes increasing access to Occupational Health, a digital information service for employers and the Disability Confident scheme. Guidance for businesses on supporting employee work-life balance through measures such as flexible working and parental leave can be found on gov.uk and the Help to Grow website.


Written Question
Employment: Multiple Sclerosis
Wednesday 9th July 2025

Asked by: Olly Glover (Liberal Democrat - Didcot and Wantage)

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what steps she is taking through the Get Britain Working White Paper to support people with multiple sclerosis (a) into and (b) to stay in work.

Answered by Alison McGovern - Minister of State (Housing, Communities and Local Government)

Good work is generally good for health and wellbeing, so we want everyone to get work and get on in work, whoever they are and wherever they live. Disabled people and people with health conditions, including multiple sclerosis, are a diverse group so access to the right work and health support, in the right place, at the right time, is key. We therefore have a range of specialist initiatives to support individuals to stay in work and get back into work, including those that join up employment and health systems. Measures include support from Work Coaches and Disability Employment Advisers in Jobcentres and Access to Work grants, as well as joining up health and employment support around the individual through Employment Advisors in NHS Talking Therapies and Individual Placement and Support in Primary Care.

Building on our WorkWell, Employment Advisers in Talking Therapies and Connect to Work programmes, we will ensure people with a health condition have access to the holistic support they need. In the Government’s Pathways to Work Green Paper, we further committed to developing a support guarantee, so that disabled people and those with a health condition get the work, health and skills support they need to access and thrive in employment.

And we are delivering the biggest investment in support for disabled people and people with health conditions in at least a generation. Our support guarantee announced as part of the Green Paper is backed up by £2.2bn over four years, including £200m in 2026/27 when our benefit changes begin to take effect and, as announced in the statement on Welfare Reform (30 June) by the Secretary of State for Work and Pensions, an additional £300m over the next 3 years. This brings our total investment in employment support for disabled people and those with health conditions to £3.8 billion over this Parliament.

We will further pilot the integration of employment advisers and work coaches into the neighbourhood health service, so that working age people with long term health conditions have an integrated public service offer. A patient’s employment goals will be part of care plans, to support more joined up service provision. The Department for Work and Pensions and the Department of Health and Social Care have worked together on the 10 Year Health Plan. The 10 Year Health Plan will ensure a better health service for everyone, regardless of condition or service area. The Plan sets out the vision for what good joined-up care looks like for people with a combination of health and care needs, including for disabled people.

Backed by £240m investment, the Get Britain Working White Paper launched in November 2024, will drive forward approaches to tackling economic inactivity and work toward the long-term ambition of an 80% employment rate. In recognition of the key role employers play a key role in increasing employment opportunities and supporting disabled people and people with health conditions, the Secretaries of State for Work and Pensions and Business and Trade asked Sir Charlie Mayfield to lead an independent review, considering how best to support and enable employers to recruit and retain more people with health conditions and disabilities, promote healthy workplaces, and support more people to stay in or return to work from periods of sickness absence. Sir Charlie will deliver his final report in the autumn. Employers are crucial in enhancing employment opportunities and supporting disabled people and those with health conditions to thrive in the workforce. Our support to employers includes increasing access to Occupational Health, a digital information service for employers and the Disability Confident scheme. Guidance for businesses on supporting employee work-life balance through measures such as flexible working and parental leave can be found on gov.uk and the Help to Grow website.


Written Question
Multiple Sclerosis
Monday 23rd June 2025

Asked by: Juliet Campbell (Labour - Broxtowe)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support people with Multiple Sclerosis.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Integrated care boards (ICBs) are responsible for commissioning services for their local population, including for multiple sclerosis (MS). The Government expects ICBs to assess the demand for service provision when designing their local services.

There are initiatives to support better care for patients with neurological conditions like MS, across England. These include the Getting It Right First Time Programme for Neurology, which aims to improve MS care by supporting the National Health Service to address variations in care and by promoting best practice.

The Progressive Neurological Conditions Toolkit, published by NHS England’s RightCare Programme, supports healthcare systems in improving the care of individuals living with progressive neurological conditions, including MS. It aims to enhance local services and reduce hospital admissions by focusing on preventative care and by optimising the delivery of services.

NHS England’s Neurology Transformation Programme (NTP) is a multi-year programme to develop a new model of integrated care for neurology services. The NTP has collaborated with clinicians and patient groups to create specific pathways for MS, aiming to improve the quality and coordination of care.

NHS England is also updating its Specialised Neurology service specification, which includes MS. Service specifications define the standards of care expected from organisations funded by NHS England to provide specialised care.

Our 10-Year Health Plan will set out a bold agenda to deliver on the three big shifts needed, to move healthcare from the hospital to the community, from analogue to digital, and from treatment to prevention. We also plan to publish our refreshed Long Term Workforce Plan to deliver a transformed health service over the next decade and to treat patients wherever they live in England, including those with MS, on time again.


Written Question
Multiple Sclerosis: Stem Cells
Monday 23rd June 2025

Asked by: Sarah Gibson (Liberal Democrat - Chippenham)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many patients have been prescribed stem cell transplantation therapy for MS in the last five years, by NHS region.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Whilst there is no data available for how many people with multiple sclerosis (MS) have been prescribed a stem cell transplant, the British Society for Blood and Marrow Transplant and Cellular Therapy (BSBMTCT) reports that, between 2018 and 2022, there were 232 autologous stem cell transplants performed for MS in England. There may be patients for whom a stem cell transplant was prescribed but they did not go ahead with the transplant.

This data has not been made available to NHS England by BSBMTCT by National Health Service region.


Written Question
Multiple Sclerosis: Woking
Monday 23rd June 2025

Asked by: Will Forster (Liberal Democrat - Woking)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support people diagnosed with multiple sclerosis in Woking constituency.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Integrated care boards (ICBs) are responsible for commissioning services for their local population, including for multiple sclerosis (MS). The Government expects ICBs, including the Surrey Heartlands ICB, which covers the Woking constituency, to assess the demand for service provision in designing their local services.

There are initiatives to support better care for patients with neurological conditions, such as MS, across England, including in the Woking constituency. These include the Getting It Right First Time Programme for Neurology, which aims to improve MS care by supporting the National Health Service to address variations in care and by promoting best practice.

The Progressive Neurological Conditions Toolkit, published by NHS England’s RightCare Programme, supports healthcare systems in improving the care of individuals living with progressive neurological conditions, including MS. It aims to enhance local services and reduce hospital admissions by focusing on preventative care and optimising the delivery of services.

NHS England’s Neurology Transformation Programme (NTP) is a multi-year programme to develop a new model of integrated care for neurology services. The NTP has collaborated with clinicians and patient groups to create specific pathways for MS, aiming to improve the quality and coordination of care.

NHS England is also updating its Specialised Neurology service specification, which includes MS. Service specifications define the standards of care expected from organisations funded by NHS England to provide specialised care.

Our 10-Year Health Plan will set out a bold agenda to deliver on the three big shifts needed, to move healthcare from the hospital to the community, from analogue to digital, and from treatment to prevention. We also plan to publish our refreshed Long Term Workforce Plan to deliver a transformed health service over the next decade and to treat patients wherever they live in England, including those with MS, on time again.


Written Question
Personal Independence Payment: Multiple Sclerosis
Monday 23rd June 2025

Asked by: Sarah Gibson (Liberal Democrat - Chippenham)

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what recent estimate she has made of the number of people with multiple sclerosis who are expected to lose eligibility for Personal Independence Payment under the proposed reforms to the assessment criteria.

Answered by Stephen Timms - Minister of State (Department for Work and Pensions)

I refer the hon. Member to the answer to Question UIN 58296 on 16th June 2025.


Written Question
Personal Independence Payment: Multiple Sclerosis
Monday 23rd June 2025

Asked by: Sarah Gibson (Liberal Democrat - Chippenham)

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what proportion of PIP decisions for people with MS have been overturned on appeal in the last five years, by region.

Answered by Stephen Timms - Minister of State (Department for Work and Pensions)

For the proportion of Personal Independence Payment (PIP) New Claim and DLA reassessment decisions, for claimants with MS as main medical condition, overturned at appeal stage by region for the last five Financial Years, see Table 1 below.

Table 1: the percentage of PIP New Claim and DLA reassessment decisions, for claimants with MS as main medical condition, overturned at appeal stage by region for the last five Financial Years

Region of Initial New Claim or DLA reassessment decision

Financial Year of Initial Decision

2019-20

2020-21

2021-22

2022-23

2023-24

East Midlands

9%

6%

10%

6%

6%

East of England

6%

6%

8%

9%

5%

London

9%

7%

10%

8%

5%

North East

5%

3%

8%

6%

6%

North West

7%

8%

8%

11%

6%

South East

7%

7%

8%

9%

4%

South West

7%

7%

11%

8%

4%

West Midlands

7%

3%

5%

10%

6%

Yorkshire and The Humber

8%

7%

6%

7%

6%

Total England

7%

6%

8%

8%

5%

Wales

8%

3%

12%

7%

7%

For the proportion of Personal Independence Payment (PIP) Award Review and Change of Circumstances decisions, for claimants with MS as main medical condition, overturned at appeal stage by region for the last five Financial Years, see Table 2 below.

Table 2: the percentage of PIP Award Review and Change of Circumstances decisions, for claimants with MS as main medical condition, overturned at appeal stage by region for the last five Financial Years

Region of Initial Award Review and Change of Circumstances decision

Financial Year of Initial Decision

2019-20

2020-21

2021-22

2022-23

2023-24

East Midlands

4%

2%

2%

3%

5%

East of England

3%

2%

2%

2%

2%

London

6%

2%

3%

3%

5%

North East

3%

1%

1%

1%

3%

North West

3%

2%

2%

3%

3%

South East

5%

3%

2%

2%

4%

South West

4%

3%

3%

3%

4%

West Midlands

5%

3%

1%

4%

6%

Yorkshire and The Humber

3%

2%

2%

3%

4%

Total England

4%

2%

2%

3%

4%

Wales

4%

2%

2%

5%

4%

Source(s): PIP Administrative Data

Notes:

  • Figures for England and Wales only.
  • Percentages have been rounded to the nearest whole number.
  • These figures include appeal clearances and decisions for PIP New Claims, Reassessments, Award Reviews and Change of Circumstances. These figures include appeals cleared from April 2019 to December 2024, in line with latest PIP statistics Personal Independence Payment: Clearance/Outstanding Times and Customer Journey Statistics to January 2025, England & Wales (XLS).
  • Appeals data has been taken from DWP PIP customer system’s management information. Therefore, this appeal data may differ from that held by His Majesty’s Courts and Tribunals Service for various reasons such as delays in data recording and other methodological differences in collating and preparing statistics.
  • This data is unpublished data. It should be used with caution, and it may be subject to future revision.
  • Figures include appeals overturns following tribunal hearing and lapsed appeals.
  • A lapsed appeal is where DWP changed the decision in the customer’s favour after an appeal was lodged but before it was heard at a tribunal hearing.
  • An overturned appeal is where the decision was changed in the customer’s favour after an appeal was lodged and was heard at tribunal hearing.
  • Appeals can have their decision upheld or may also be withdrawn by the claimant. These are not included in the above tables.


Written Question
Multiple Sclerosis: Nurses
Friday 20th June 2025

Asked by: Sarah Gibson (Liberal Democrat - Chippenham)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many full-time equivalent MS specialist nurses are employed by the NHS in England; and steps he plans to take to increase their number.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department does not hold information on the number of full time equivalent multiple Sclerosis (MS) nurses employed in the National Health Service in England.

The Nursing and Midwifery Council (NMC) sets the standards for nurse education. There is no NMC requirement for specific post-graduate education for nurses working with those with MS; however, the education and practice learning that prepares nurses to join the register covers learning outcomes to support good care.

Local employers will plan the specialist nurse workforce they require to meet population needs. The NHS funds several post registration education programmes that supports the development of the knowledge and skills required in practice. Each nurse working in the NHS also has access to a continuing professional development budget of £1,000 over three years to enable them to develop their knowledge and skills.


Written Question
Multiple Sclerosis: Medical Treatments
Wednesday 18th June 2025

Asked by: Sarah Gibson (Liberal Democrat - Chippenham)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the availability of high-efficacy treatments for relapsing-remitting MS on the NHS.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new medicines should be routinely funded by the NHS based on an assessment of their costs and benefits. The NHS in England is legally required to fund medicines recommended by NICE, which has recommended a number of new medicines for use in the treatment of relapsing-remitting multiple sclerosis (MS) that are now routinely available for use in the treatment of NHS patients.

Most recently, in April 2025, NICE recommended cladribine for treating active relapsing-remitting forms of MS. In December 2024, NICE had already recommended ublituximab for treating relapsing-remitting MS.